These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27042659)

  • 1. Improved Stability of a Model IgG3 by DoE-Based Evaluation of Buffer Formulations.
    Chavez BK; Agarabi CD; Read EK; Boyne MT; Khan MA; Brorson KA
    Biomed Res Int; 2016; 2016():2074149. PubMed ID: 27042659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.
    Kolhe P; Amend E; Singh SK
    Biotechnol Prog; 2010; 26(3):727-33. PubMed ID: 20039442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-buffering antibody formulations.
    Gokarn YR; Kras E; Nodgaard C; Dharmavaram V; Fesinmeyer RM; Hultgen H; Brych S; Remmele RL; Brems DN; Hershenson S
    J Pharm Sci; 2008 Aug; 97(8):3051-66. PubMed ID: 18023013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freeze/thaw of IGG solutions.
    Horn J; Jena S; Aksan A; Friess W
    Eur J Pharm Biopharm; 2019 Jan; 134():185-189. PubMed ID: 30529434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
    Gibson TJ; Mccarty K; Mcfadyen IJ; Cash E; Dalmonte P; Hinds KD; Dinerman AA; Alvarez JC; Volkin DB
    J Pharm Sci; 2011 Mar; 100(3):1009-21. PubMed ID: 21280052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches.
    Kim NA; Song K; Lim DG; Hada S; Shin YK; Shin S; Jeong SH
    Eur J Pharm Sci; 2015 Oct; 78():177-89. PubMed ID: 26215462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
    Barnard JG; Singh S; Randolph TW; Carpenter JF
    J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ionic interactions on protein stability prediction using solid-state hydrogen deuterium exchange with mass spectrometry (ssHDX-MS).
    AbouGhaly MHH; Du J; Patel SM; Topp EM
    Int J Pharm; 2019 Sep; 568():118512. PubMed ID: 31301464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: from protein buffer capacity prediction to bioprocess applications.
    Bahrenburg S; Karow AR; Garidel P
    Biotechnol J; 2015 Apr; 10(4):610-22. PubMed ID: 25641961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
    Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
    J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis.
    He F; Woods CE; Trilisky E; Bower KM; Litowski JR; Kerwin BA; Becker GW; Narhi LO; Razinkov VI
    J Pharm Sci; 2011 Apr; 100(4):1330-40. PubMed ID: 24081468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody.
    Awotwe-Otoo D; Agarabi C; Wu GK; Casey E; Read E; Lute S; Brorson KA; Khan MA; Shah RB
    Int J Pharm; 2012 Nov; 438(1-2):167-75. PubMed ID: 22944306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of formulation variables on protein stability and integrity of a model IgG4 monoclonal antibody and translation to formulation of a model ScFv.
    Gourbatsi E; Povey JF; Smales CM
    Biotechnol Lett; 2018 Jan; 40(1):33-46. PubMed ID: 28939995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298.
    Zheng JY; Janis LJ
    Int J Pharm; 2006 Feb; 308(1-2):46-51. PubMed ID: 16316730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buffer capacity of biologics--from buffer salts to buffering by antibodies.
    Karow AR; Bahrenburg S; Garidel P
    Biotechnol Prog; 2013; 29(2):480-92. PubMed ID: 23296746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freezing-induced perturbation of tertiary structure of a monoclonal antibody.
    Liu L; Braun LJ; Wang W; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Jul; 103(7):1979-1986. PubMed ID: 24832730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
    Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
    AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term stability tests by analyzing size exclusion liquid chromatographic profiles.
    Hernández-Jiménez J; Martínez-Ortega A; Salmerón-García A; Cabeza J; Prados JC; Ortíz R; Navas N
    Int J Biol Macromol; 2018 Oct; 118(Pt A):511-524. PubMed ID: 29944945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage.
    Svilenov H; Winter G
    Eur J Pharm Biopharm; 2019 Apr; 137():131-139. PubMed ID: 30818009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.